Skip to main content

Venipuncture

0
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

AIRS Medical
AIRS MedicalKorea - Seoul
1 program
AIIV L2N/A1 trial
Active Trials
NCT07383870Recruiting190Est. Apr 2026
Vitestro
VitestroNetherlands - Utrecht
1 program
Venipuncture DeviceN/A1 trial
Active Trials
NCT05878483Recruiting44,658Est. Dec 2029

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
2028
2029
AIRS MedicalAIIV L2
VitestroVenipuncture Device

Clinical Trials (2)

Total enrollment: 44,848 patients across 2 trials

Clinical Evaluation of an AI- and Ultrasound-Assisted Venipuncture Device

Start: Jan 2026Est. completion: Apr 2026190 patients
N/ARecruiting
NCT05878483VitestroVenipuncture Device

Autonomous Blood Drawing Optimization and Performance Testing

Start: Jul 2023Est. completion: Dec 202944,658 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 44,848 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.